Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.3083
-0.0016-0.52%
Volume:507.12K
Turnover:153.24K
Market Cap:19.11M
PE:-0.43
High:0.3100
Open:0.3100
Low:0.2900
Close:0.3099
Loading ...

Cognition Therapeutics Launches Expanded Access Program for Zervimesine

TIPRANKS
·
03 Jun

Cognition Therapeutics Advances to Phase 3 Trials

TIPRANKS
·
02 Jun

Cognition Therapeutics price target lowered to $3 from $5 at H.C. Wainwright

TIPRANKS
·
27 May

Cognition Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $3 From $5

THOMSON REUTERS
·
27 May

Cognition Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Cognition Therapeutics Q1 Net Income USD -8.48 Million

THOMSON REUTERS
·
07 May

Cognition Therapeutics Inc: Qtrly Shr Loss $0.14

THOMSON REUTERS
·
07 May

Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update

Dow Jones
·
07 May

Cognition Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
02 May

Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications

TIPRANKS
·
25 Mar

Cognition Therapeutics Earnings Call: Progress Amid Challenges

TIPRANKS
·
22 Mar

Cognition Therapeutics Inc (CGTX) Q4 2024 Earnings Call Highlights: Strategic Focus on ...

GuruFocus.com
·
21 Mar

Cognition Therapeutics Advances Alzheimer’s and DLB Trials

TIPRANKS
·
21 Mar

Cognition Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Mar

Cognition Therapeutics FY 2024 EPS $(0.86) Misses $(0.76) Estimate

Benzinga
·
20 Mar

Cognition Therapeutics FY Net Income USD -33.971 Million

THOMSON REUTERS
·
20 Mar

Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
20 Mar

Press Release: Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update

Dow Jones
·
20 Mar

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire
·
14 Mar

Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results

GlobeNewswire
·
14 Mar